Sch

Arizona Cancer Center Home Page :: Shared Services :: TACMASS

Representative Publications

2007

Chandramouli A, Shi J, Feng Y, Holubec H, Shanas R, Bhattacharyya A, Zheng W, Nelson MA. Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice. Carcinogenesis (accepted) 2007.

De Clerck YA, Weissman BE, Yu D, Parsons R, Bar-Eli M, Roy-Burman P, Seewaldt VL, Cress AE, Languino LR, Batra SK, Tang CK, Sheng S, Chen WT, Chellappan S, Cheng SY, Ladisch S, McCarthy JB, Coussens LM, Cohen MB. Tumor Progression and Metastasis from Genetic to Microenvironmental Determinants: A Workshop of the Tumor Progression and Metastasis NIH Study Section in Honor of Dr. Martin L. Padarathsingh, May 31, 2006, Georgetown, Washington, DC. Cancer Biol Ther. 2006 Dec;5(12):1588-99. Epub 2006 Dec 6. No abstract available.

PMID: 17224636 [PubMed - in process]

Dragovich T, McCoy S, Urba S, Zaner K, Benedetti JK, Baker A, Wang, J, Hackett C, Fenoglio-Preiser C, Blanke C and Abbruzzese J. SWOG 0127: Phase II Trial of Erlotinib in Gastroesophageal Junction GEJ and Gastric Adenocarcinomas. J Clin Onc: Vol 24 (30): 4922-4927, 2006.

Gard JMC, Averill J, Vanpatten KA, Pestano G, Nagle RB: Investigation into the Role of PI-3Kinase Pathway in Translational Repression in Prostate Carcinoma. Abstract presented at KeystoneConference for PI3Kinase Santa Fe, New Mexico, Feb 2007.

Garland L, Rankin C, Gandara D, Rivkin S, Scott K, Nagle R, Altomare D, Klein-Szanto A, Testa R, Borden E. A Phase II study of oral EGFR tyrosine kinase inhibitor erlotinib in patients with malignant pleural mesothelioma: A Southwest Oncology Group Study. Accepted for publication, J Clin Oncol.

Ignatenko NA; Holubec H; Besselsen DG; Blohm-Mangone KA; Padilla-Torres JL; Nagle RB; Moreno de Alborqin I; Guillen-R JM; Gerner EW: Role of c-Myc in Intestinal Tumroigenesis of the Apc Min/+ Mouse. Cancer Biology & Therapy 5:12, 1658-1664, Dec 2006.

Jacobson, E.L., Kim, H., Kim, M., Williams, J.D., Coyle, D.L., Coyle, W.R., Grove, G., Rizer, R.L., Stratton, M. and Jacobson, M.K. A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier function in photodamaged skin. (2007) Journal of Investigative Dermatology, abstract submitted for 68th Annual Meeting to be held May 9-12, 2007 in Los Angeles, California.

Jacobson, M.K., Kim, H., Coyle, W.R., Kim, M., Coyle, D.L., Rizer, R.L., and Jacobson, E.L. Myristyl nicotinate mitigates skin barrier impairment and improves tolerability of retinoic acid therapy. (2007) Journal of Investigative Dermatology, abstract submitted for 68th Annual Meeting to be held May 9-12, 2007 in Los Angeles, California.

Mahadevan D, Cooke L, Riley C, Swart R, Simons B, Della Croce K, Wisner L, Iorio M, Shakalya K, Garewal H, Nagle, R and Bearss D: A novel tyrosine kinase switch is a mechanism of imatinib rresistance in gastrointestinal stromal tumors. Oncogene (2007) 1-11.

Morse DL, Galons JP, Payne CM, Jennings DL, Day S, Xia G and RJ Gillies. MRI-measured water mobility increases in response to chemotherapy via multiple cell-death mechanisms. NMR Biomed (in press).

David Morse, J.P. Galons, Claire Payne, Dominique Jennings, Robert Gillies. (2006) Increased tumor water mobility in response to docetaxel therapy is correlated with multiple cell death mechanisms. Society for Molecular Imaging annual meeting abstract.

Pawar SC, Demetriou MC, Nagle RB, Bowden GT, Cress AE. Integrin alpha6 cleavage: A novel modification

to modulate cell migration. Exp Cell Res. 2007 Jan 17; [Epub ahead of print]

Pochampalli, M.R., Bitler, B.G. and Schroeder, J.A. Transforming Growth Factor alpha-Dependent Cancer

Progression is Modulated by Muc1, Cancer Research, in press, 2007.

Sroka TC, Marik J, Pennington ME, Lam KS, Cress AE.

The minimum element of a synthetic Peptide required to block prostate tumor cell migration. Cancer Biol Ther. 2006 Nov;5(11):1556-62. Epub 2006 Nov 30.
PMID: 17102593 [PubMed - in process]

Sroka TC, Pennington ME, Cress AE.: Synthetic D-amino acid peptide inhibits tumor cell motility on laminin-5. Carcinogenesis. 2006 Sep;27(9):1748-57. Epub 2006 Mar 14.

2006

Bredfeldt TG, Jagadish B, Eblin KE, Mash, EA, Gandolfi AJ. Monomethylarsonous Acid Induces Transformation of Human Bladder Cells. Toxicol. Appl. Pharmacol., Accepted with revision, 2005.

Natalia A. Ignatenko, Hana Holubec, David G. Besselsen, Karen A. Blohm-Mangone, Jose L. Padilla-Torres, Erika Dexter, Raymond B. Nagle, Ignacio Moreno de Alboran, Jose M. Guillen-R, and Eugene W. Gerner Role of c-Myc in intestinal development and tumorigenesis of the Apc Min/+ mouse. Submitted, Cancer Research, March 2006

Kremer CL, Klein RR, Mendelson J, Browne W, Samadzedeh LK, Vanpatten K, Highstrom L, Pestano G, Nagle RB. Expression of mTOR signaling pathway markers in prostate cancer progression. Prostate, in press, 2006.

Lopez J, Camenisch TD, Stevens MV, Sands BJ, McDonald J, and Schroeder JA. CD44 attenuates metastatic invasion during breast cancer progression. Cancer Res 65:15, pp6755-6763, Aug 1, 2005.

Pawar, S, King, T., Porreca, F., Nagle, R.B. and Cress, A.E. Integrin Clipping: Enhancing osetolytic activity in prostate cancer. In Skeletal Complications in Malignancies Conference in Bethesda, MD. April 28-30, 2005.

Watts GS, Tran NL, Berens ME, Bhattacharyya AK, Sampliner RE. Microarray analysis of esophageal adenocarcinoma identifies potential therapeutic targets including Fn14/TWEAK receptor. 2006, Submitted.

Wenqing Qi, Xiaobing Liu, Dianhua Qiao, and Jesse Martinez. Isoform-Specific Expression of 14-303 Proteins in Human Lung Cancer Tissues. Int J Cancer: 113:359-363, 2005.

2005

Natalia A. Ignatenko, Hana Holubec, David G. Besselson, Karen A Blohm-Mangone, Jose L. Padilla-Tores, Erika L. Dexter, Raymond B. Nagle, Eugene W. Guerner. Role of c-myc in normal intestinal development and tumorigenesis in the Apc Min/+ Mouse. Presented AACR, 2005.

Linda K. Samadzadeh, Erika Dexter, Linda A Pestano, Jean Cubberley, Edward Hughes Jr., Paul Beresford, Thomas M. Grogan, Raymond B. Nagle, Gary A. Pestano. Immunohistochemistry Diagnostic Methods Development for Phospho-protein Detection in Formalin-Fixed Paraffin Embedded (FFPE) Tissues. Poster Abstract presented at Keystone Symposium: Targets fro Cancer Therapy, Jan 6-11, 2005, Santa Fe, New Mexico.

Holly McKlveen Buschhorn, Robert R. Klein, Susan M. Chambers, Margaret C. Hardy, Sylvan Green, David Bearss, Raymond B. Nagle. Aurora-A over expression in high grade PIN lesions and prostate cancer. Accepted The Prostate.

Calalcuce, R, Bearss, D, Barrera J, Zhao Y, Han Y, Beck S, McDaniel K, Nagle RB. Laminin 5 beta 3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumorigenicity. Neoplasia 6:5, 468-479, 2004.

EL Bair, ML Chen, K McDaniel, K Sekiguchi, AE Cress, RB Nagle, GT Bowden; Membrane-Type-1 Matrix Metalloproteinase (MT1-MMP) Cleaves Laminin-10 and Promotes Prostate Cancer Cell Invasion. Neoplasia, April 2005.

Demetriou, MC, Pennington, ME, Nagle, RB and Cress, AE. Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer. Exp. Cell Res 2004 294: 550-558.

Chauhan S, Kunz S, Davis K, Roberts J, Martin G, Demetrious MC, Sroka TC, Cress AE, Meisfeld RL. Androgen control of cell proliferation and cytoskeletal reorganization in human fibrosarcoma cells: rols of RhoB signaling. J Biol Chem 2004 Jan 9;279(2): 937-44, Epub 2003 Oct 23.

L. Garland, C. Rankin, K. Scott, R. Nagle, M. Lobell, D. Gandara, S Rivkin, W Samlowski, J Atkins, E Borden. Molecular Correlates of the EGFR signaling pathway in association with SOWG S0218: A Phase II study of oral EGFR Tyrosine Kinase Inhibitor OSI-774 (NSC-718781) in patients with malignant pleural mesothelioma (MPM). Abstract submission, American Society of Clinical Oncology, Dec 12, 2003.

Monika Schmelz, Roland Moll, Ulrike Hesse, Anil Prasad, Jay Gandolfi, Shirin Hasane, Marty Bartholdie and Anne E. Cress. Identification of a stem cell candidate in the normal human prostate gland. Eur J Cell Biol 84:341-345. 2005.

Adelman MK, Nagle R, Schluter SF, Marchalonis JJ, Posever JO and Yocum, DE. 2004. HTLV-1 related endogenous sequence in the etiopathogenesis of Systemic Lupus Erythematosus. Arthritis and Rheumatism 50(9):S202, abstract 408.

2004

Cory L Grand, Tiffanie J. Powell, Raymond B. Nagle, David J. Bearss, Denise Tye, Mary Gleason-Guzman, and Laurence H. Hurley. Mutations in the G-Quadruplex Silence Element and Their Relationship to c-MYC Overexpression, NM23 Repression, and Therapeutic Rescue. PNAS, in press, 2004.

Wenqing Qi, Xiaobing Liu, Dianhua Qiao and Jesse Martinez. Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Submitted to Journal of Cancer, 9 Mar 2004.

Linda Garland, C. Rankin, K. Scott, R Nagle, M Lobell, D Gandara, S Rivkin, W Samlowski, J Atkins, E Borden; Molecular Correlates of the EGFR signaling pathway in association with SWOG S0218: A Phase II Study of Oral EGFR Tyrosine Kinase Inhibitor OSI-774 (NSC-718781) in Patients with Malignant Pleural Mesothelioma (MPM). In press in Proceedings of ASCO (American Society of Clinical Oncology), 2004. Will also be presented as an oral presentation in the Molecular Therapeutics session of ASCO in June, 2004.

David Nyman, MS Stratton, M Kopplin, BL Dalkin, RB Nagle, AJ Gandolfi, Selenium and selenomethionine levels in prostate cancer patients. Cancer Detection and Prevention 28:8-16, 2004.

Holly M. Buschhorn, S Chambers, M Hardy, A Prasad, RB Nagle. Analysis of Aurora 2 kinase in prostate PIN lesions. Proceedings of the AACR, Vol 45, March 2004.